Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 128Lymphoma 107Lymphoma, Large B-Cell, Diffuse 96Leukemia 55Burkitt Lymphoma 50Lymphoma, Non-Hodgkin 49Lymphoma, Follicular 37Lymphoma, Mantle-Cell 33Hodgkin Disease 25Retinoblastoma 16Recurrence 16Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 16Lymphoma, T-Cell, Peripheral 16Lymphoma, Large-Cell, Anaplastic 16Central Nervous System Neoplasms 16Neuroblastoma 15Lymphoma, Large-Cell, Immunoblastic 15Lymphoma, B-Cell 15Sarcoma 13Rhabdomyosarcoma 12Lymphoma, B-Cell, Marginal Zone 12Neoplasms 11Medulloblastoma 11Immunoblastic Lymphadenopathy 11Sarcoma, Ewing 10Lymphoma, T-Cell 10Leukemia, Lymphocytic, Chronic, B-Cell 9Leukemia, Biphenotypic, Acute 8Dendritic Cell Sarcoma, Interdigitating 8Enteropathy-Associated T-Cell Lymphoma 7

Interventions

Lenalidomide 2Cyclophosphamide 2peginterferon alfa-2b 1etoposide phosphate 1dolutegravir 1belinostat 1Zidovudine 1Vincristine 1Tenofovir 1Raltegravir Potassium 1Prednisone 1Introns 1Granulocyte Colony-Stimulating Factor 1Etoposide 1Doxorubicin 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Leukemia-Lymphoma, Adult T-Cell × Vincristine × Clear all
NCT01000285 2017-03-28

ATLL

Washington University School of Medicine

Phase 1/2 Completed
18 enrolled 13 charts
LymphoidOther hematologic neoplasm

Leukemia-Lymphoma, Adult T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡